» Articles » PMID: 3349464

Uptake Kinetics of Monoclonal Antibodies by Human Malignant Melanoma Multicell Spheroids

Overview
Journal Cancer Res
Specialty Oncology
Date 1988 Apr 1
PMID 3349464
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Detailed uptake kinetics by multicell spheroids of three tumor associated monoclonal antibodies was investigated. The spheroids were established from a human melanoma cell line and the human colon adenocarcinoma cell line HT29 as in vitro models of poorly vascularized micrometastases in vivo. The selected antibodies 96.5, 140.240, and OST15 showed a wide range of reactivity against the melanoma cell but they all had negligible binding with the colon cancer cell. Uptake of the antibodies by small spheroids (about 300 micron diameter) was generally sigmoidal in shape with respect to incubation time, and amount of uptake followed the same trend of immunoreactivity of the antibodies with single cells. The correlation was weaker for spheroids with diameter greater than 500 micron presumably due to the increasing size of the necrotic core. By varying the concentration of the antibodies in the incubation medium from tracer dose (0.2 microgram/ml) to a higher dose (3 micrograms/ml), negligible changes in the amount of antibodies bound with their target spheroids were observed. Nonspecific binding between antibodies and spheroids, however, resulted in proportional increase in uptake.

Citing Articles

A multiparametric analysis including single-cell and subcellular feature assessment reveals differential behavior of spheroid cultures on distinct ultra-low attachment plate types.

Vitacolonna M, Bruch R, Agaci A, Nurnberg E, Cesetti T, Keller F Front Bioeng Biotechnol. 2024; 12:1422235.

PMID: 39157442 PMC: 11327450. DOI: 10.3389/fbioe.2024.1422235.


Analysis of the Equilibrium Phase in Immune-Controlled Tumors Provides Hints for Designing Better Strategies for Cancer Treatment.

Atsou K, Khou S, Anjuere F, Braud V, Goudon T Front Oncol. 2022; 12:878827.

PMID: 35832538 PMC: 9271975. DOI: 10.3389/fonc.2022.878827.


Complement-mediated killing of microtumors in vitro.

Hakulinen J, Meri S Am J Pathol. 1998; 153(3):845-55.

PMID: 9736033 PMC: 1853009. DOI: 10.1016/S0002-9440(10)65626-X.


Diffusion of an anti-transferrin receptor antibody in cultured murine melanoma cell layers.

Vijaykumar V, Topp E Pharm Res. 1995; 12(12):1907-16.

PMID: 8786965 DOI: 10.1023/a:1016424321378.


The selection of antibodies for targeted therapy of small-cell lung cancer (SCLC) using a human tumour spheroid model to compare the uptake of cluster 1 and cluster w4 antibodies.

Olabiran Y, Ledermann J, Marston N, Boxer G, Hicks R, Souhami R Br J Cancer. 1994; 69(2):247-52.

PMID: 8297722 PMC: 1968697. DOI: 10.1038/bjc.1994.47.